149 related articles for article (PubMed ID: 21944756)
1. Design of a heterobivalent ligand to inhibit IgE clustering on mast cells.
Handlogten MW; Kiziltepe T; Moustakas DT; Bilgiçer B
Chem Biol; 2011 Sep; 18(9):1179-88. PubMed ID: 21944756
[TBL] [Abstract][Full Text] [Related]
2. A heterobivalent ligand inhibits mast cell degranulation via selective inhibition of allergen-IgE interactions in vivo.
Handlogten MW; Serezani AP; Sinn AL; Pollok KE; Kaplan MH; Bilgicer B
J Immunol; 2014 Mar; 192(5):2035-41. PubMed ID: 24489096
[TBL] [Abstract][Full Text] [Related]
3. Highly effective poly(ethylene glycol) architectures for specific inhibition of immune receptor activation.
Baird EJ; Holowka D; Coates GW; Baird B
Biochemistry; 2003 Nov; 42(44):12739-48. PubMed ID: 14596588
[TBL] [Abstract][Full Text] [Related]
4. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
5. Interaction of antigen-specific T cell factors with unique "receptors" on the surface of mast cells: demonstration in vitro by an indirect rosetting technique.
Kops SK; Ratzlaff RE; Meade R; Iverson GM; Askenase PW
J Immunol; 1986 Jun; 136(12):4515-24. PubMed ID: 2423595
[TBL] [Abstract][Full Text] [Related]
6. Requirements for effective IgE cross-linking on mast cells and basophils.
Knol EF
Mol Nutr Food Res; 2006 Jul; 50(7):620-4. PubMed ID: 16764017
[TBL] [Abstract][Full Text] [Related]
7. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
[TBL] [Abstract][Full Text] [Related]
8. Interaction of a monoclonal IgE-specific antibody with cell-surface IgE-Fc epsilon RI: characterization of equilibrium binding and secretory response.
Posner RG; Paar JM; Licht A; Pecht I; Conrad DH; Hlavacek WS
Biochemistry; 2004 Sep; 43(35):11352-60. PubMed ID: 15366945
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of parthenolide on antigen-induced microtubule formation and degranulation in mast cells.
Miyata N; Gon Y; Nunomura S; Endo D; Yamashita K; Matsumoto K; Hashimoto S; Ra C
Int Immunopharmacol; 2008 Jun; 8(6):874-80. PubMed ID: 18442792
[TBL] [Abstract][Full Text] [Related]
10. Design of a heterotetravalent synthetic allergen that reflects epitope heterogeneity and IgE antibody variability to study mast cell degranulation.
Handlogten MW; Kiziltepe T; Bilgicer B
Biochem J; 2013 Jan; 449(1):91-9. PubMed ID: 23050868
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of the antigen-independent cytokinergic SPE-7 IgE activation of human mast cells in vitro.
Bax HJ; Bowen H; Dodev TS; Sutton BJ; Gould HJ
Sci Rep; 2015 Apr; 5():9538. PubMed ID: 25892150
[TBL] [Abstract][Full Text] [Related]
12. Aspergillus oryzae lectin induces anaphylactoid oedema and mast cell activation through its interaction with fucose of mast cell-bound non-specific IgE.
Yamaki K; Yoshino S
Scand J Immunol; 2011 Nov; 74(5):445-53. PubMed ID: 21790704
[TBL] [Abstract][Full Text] [Related]
13. Synthetic allergen design reveals the significance of moderate affinity epitopes in mast cell degranulation.
Handlogten MW; Kiziltepe T; Alves NJ; Bilgicer B
ACS Chem Biol; 2012 Nov; 7(11):1796-801. PubMed ID: 22877585
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of weak-affinity epitope-IgE interactions prevents mast cell degranulation.
Handlogten MW; Kiziltepe T; Serezani AP; Kaplan MH; Bilgicer B
Nat Chem Biol; 2013 Dec; 9(12):789-95. PubMed ID: 24096304
[TBL] [Abstract][Full Text] [Related]
15. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge.
Christensen LH; Holm J; Lund G; Riise E; Lund K
J Allergy Clin Immunol; 2008 Aug; 122(2):298-304. PubMed ID: 18572230
[TBL] [Abstract][Full Text] [Related]
16. Inorganic arsenite inhibits IgE receptor-mediated degranulation of mast cells.
Hutchinson LM; Trinh BM; Palmer RK; Preziosi CA; Pelletier JH; Nelson HM; Gosse JA
J Appl Toxicol; 2011 Apr; 31(3):231-41. PubMed ID: 20842677
[TBL] [Abstract][Full Text] [Related]
17. Degranulation of in vitro differentiated mast cells stimulated by two monoclonal IgE specificities.
Rofolovitch M; Amira M; Ginsburg H
Eur J Immunol; 1987 Mar; 17(3):385-92. PubMed ID: 2436921
[TBL] [Abstract][Full Text] [Related]
18. Binding mechanisms of PEGylated ligands reveal multiple effects of the PEG scaffold.
Das R; Baird E; Allen S; Baird B; Holowka D; Goldstein B
Biochemistry; 2008 Jan; 47(3):1017-30. PubMed ID: 18154361
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous cross-linking by two nontriggering bivalent ligands causes synergistic signaling of IgE Fc epsilon RI complexes.
Posner RG; Subramanian K; Goldstein B; Thomas J; Feder T; Holowka D; Baird B
J Immunol; 1995 Oct; 155(7):3601-9. PubMed ID: 7561059
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies specific to the alpha-subunit of the mast cell's Fc epsilon R block IgE binding and trigger histamine release.
Baniyash M; Alkalay I; Eshhar Z
J Immunol; 1987 May; 138(9):2999-3004. PubMed ID: 2437203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
